Article Sidebar

Submitted
Dec 19, 2023
Published
Dec 19, 2023
Download
PDF
Statistic
Read Counter : 35 Download : 25

Main Article Content

Abstract

Cancer is known to be the second most common cause of death, surpassed only by cardiovascular disease. So there has been intense research on various plant resources to develop novel anticancer agents. From the past several years medicinal plants have been proven to be an important natural source for cancer therapy with fewer side effects. There are many natural cytotoxic drugs available, which need further improvement and development of new drugs. The basic aim of this review is to explore the potential of newly discovered anticancer compounds from medicinal plants, as a lead for anticancer drug development. It will be helpful to explore the medicinal value of plants and for new drug discovery from them for the researchers and scientists around the globe.

Keywords

anti-cancer agents medicinal plants cancer prevention apoptosis

Article Details

How to Cite
Raja Rajeswari Kamisetti. (2023). A Critical Review On Medicinal Plants With Anti-Cancer Activity. International Journal of Research in Pharmacology & Pharmacotherapeutics, 12(4), 341-353. Retrieved from https://ijrpp.com/ijrpp/article/view/516
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. 1. Ali MS, Shuaib M, Ansari SH. Withanolides from the stem bark of Withania somnifera. Phytochemistry. 1997;44(6):1163-8. doi: 10.1016/S0031-9422(96)00656-5.
  2. 2. Ambasta SP. The useful plant of India. 4th ed; 2000. National Institution of Sci. Communication, Delhi:239.
  3. 3. Ambasta SP. The useful plant of India. 4th ed; 2000. National Institution of Sci. Communication, Delhi:243.
  4. 4. Ancuceanu RV, Istudor V. Pharmacologically active natural compounds for lung cancer. Altern Med Rev. 2004;9(4):402-19. PMID 15656712.
  5. 5. Asthana RR, MK. Pharmacology of Withania somnifera- a review. Ind Drugs. 1989;26:1-7.
  6. 6. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999;58(11):1685-93. doi: 10.1016/s0006-2952(99)00212-9, PMID 10571242.
  7. 7. Belman S. Onion and garlic oils inhibit tumor promotion. Carcinogenesis. 1983;4(8):1063-65. doi: 10.1093/carcin/4.8.1063, PMID 6872151.
  8. 8. Bernard SA, Olayinka OA. Search for a novel antioxidant, antiinflammatory/ analgesic or antiproliferative drug: cucurbitacins hold the ace. J Med Plants Res. 2010;4:2821-6.
  9. 9. Scharfenberg K, Wagner R, Wagner KG. The cytotoxic effect of ajoene, a natural product from garlic, investigated with different cell lines. Cancer Lett. 1990;53(2-3):103-08. doi: 10.1016/0304-3835(90)90201-8, PMID 2208068.
  10. 10. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100(1-2):72-9. doi: 10.1016/j.jep.2005.05.011, PMID 16009521.
  11. 11. Cragg GM, Schepartz SA, Suffness M, Grever MR. The Taxol supply crisis- New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J Nat Prod. 1993;56(10):1657-68. doi: 10.1021/np50100a001, PMID 7903979.
  12. 12. Creemers GJ, Bolis G, Gore M, Scarfone G, Lacave AJ, Guastalla JP et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. J Clin Oncol. 1996;14(12):3056-61. doi: 10.1200/JCO.1996.14.12.3056, PMID 8955650.
  13. 13. Deng F, Lu JJ, Liu HY, Lin LP, Ding J, Zhang JS. Synthesis and antitumor activity of novel salvicine analogues. Chin Chem Lett. 2011;22(1):25-8. doi: 10.1016/j.cclet.2010.07.009.
  14. 14. Devi PU. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancerchemotherapy and radiosensitization. Indian J Exp Biol. 1996;34(10):927-32. PMID 9055640.
  15. 15. Devi PU, Akagi K, Ostapenko V, Tanaka Y, Sugahara T. Withaferin A: a new radiosensitizer fromthe Indian medicinal plant Withania somnifera. Int J Radiat Biol. 1996;69(2):193-97. doi: 10.1080/095530096146020, PMID 8609455.
  16. 16. Diogo CV, Félix L, Vilela S, Burgeiro A, Barbosa IA, Carvalho MJM et al. Mitochondrial toxicity of the phyotochemicals daphnetoxin and daphnoretin – relevance for possible anti-cancer application. Toxicol In Vitro. 2009;23(5):772-9. doi: 10.1016/j.tiv.2009.04.002, PMID 19362137.
  17. 17. Dixon RA, Ferreira D. Genistein. Phytochemistry. 2002;60(3):205-11. doi: 10.1016/s0031-9422(02)00116-4, PMID 12031439.
  18. 18. Dubey KK, Ray AR, Behera BK. Production of demethylated colchicine through microbial transformation and scale-up process development. Process Biochem. 2008;43(3):251-7. doi: 10.1016/j.procbio.2007.12.002.
  19. 19. Efferth T, Li PCH, Konkimalla VSB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007;13(8):353-61. doi: 10.1016/j.molmed.2007.07.001, PMID 17644431.
  20. 20. Fuchs C, Mitchell EP, Hoff PM. Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev. 2006;32(7):491-503. doi: 10.1016/j.ctrv.2006.07.001, PMID 16959432.
  21. 21. Fulda S. Betulinic acid for cancer treatment and prevention. Int J Mol Sci. 2008;9(6):1096-107. doi: 10.3390/ijms9061096, PMID 19325847.
  22. 22. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as ”Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787-809. doi: 10.1016/j.bcp.2007.08.016, PMID 17900536.
  23. 23. Hait WN, Rubin E, Alli E, Goodin S. Tubulin targeting agents. Updateon Cancer Ther. 2007;2(1):1-18. doi: 10.1016/j.uct.2006.10.001.
  24. 24. Hampson P, Wang K, Lord JM. Treatment of actinic keratoses, acute myeloid leukemia therapy, Treatment of basal cell carcinoma, protein kinase C activator. Drugs Fut. 2005;30:1003.
  25. 25. Hazra B, Sarma MD, Sanyal U. Separation methods of quinonoid constituents of plants used in oriental traditional medicines. J Chromatogr B. 2004;8(12):259-75.
  26. 26. Herst PM, Davis JE, Neeson P, Berridge MV, Ritchie DS. The anticancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica. 2009;94(7):928-34. doi: 10.3324/haematol.2008.003996, PMID 19535345.
  27. 27. Huma A, Savita D. Extraction optimization of Tinospora cordifolia and assessment of the anticancer activity of its alkaloid palmatine. Sci World J. 2013:1-10.
  28. 28. Huang Z, Chen G, Shi P. Effects of emodin on the gene expression profilingof human breast carcinoma cells. Cancer Detect Prev. 2009;32(4):286-91. doi: 10.1016/j.cdp.2008.12.003, PMID 19185431.
  29. 29. Bruneton J. Pharmacognosy, phytochemisty medicinal plants. France: Lavoisier Publisher; 1993. p. 832.
  30. 30. Bruneton J.Pharmacognosy, phytochemisty medicinal plants. France: Lavoisier Publisher;1993.p.771-77.
  31. 31. Bruneton J. Pharmacognosy, phytochemisty medicinal plants. France: Lavoisier Publisher; 1993. p. 151.
  32. 32. Bruneton J. Pharmacognosy, phytochemisty medicinal plants. France: Lavoisier Publisher; 1993. p. 281.
  33. 33. Jeena KJ, Joy KL, Kuttan R. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhizakurroa on N-nitrosodiethylamine induced hepatocardinogenesis. Cancer Lett. 1999;136(1):11-6. doi: 10.1016/s0304-3835(98)00294-8, PMID 10211933.
  34. 34. Jeong SY, Park SJ, Yoon SM, Jung J, Na Woo HN, Yi SL et al. Systemic delivery and preclinical evaluation of Au nanoparticle containing β-lapachone for radiosensitization. J Control Release. 2009;139(3):239-45. doi: 10.1016/j.jconrel.2009.07.007, PMID 19619590.
  35. 35. Khan T, Ali M, Khan A, Nisar P, Jan SA, Afridi S et al. Anticancer plants: a review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules. 2019 Dec 27;10(1):47;10(1). doi: 10.3390/biom10010047, PMID 31892257.
  36. 36. Kim S, Hwang BY, Su BN, Chai H, Mi Q, Kinghorn AD et al. Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res. 2007;27:2175-83.
  37. 37. Kinghorn AD, Carcache de Blanco EJC, Chai HB, Orjala J, Farnsworth NR, Soejarto DD et al. Discovery of anticancer agents of diverse natural origin. Pure Appl Chem. 2009;81(6):1051-63. doi: 10.1351/PAC-CON-08-10-16, PMID 20046887.
  38. 38. Kingston DGI. The shape of things to come: structural and synthetic studiesof Taxol and related compounds. Phytochemistry. 2007;68(14):1844-54. doi: 10.1016/j.phytochem.2006.11.009, PMID 17184797.
  39. 39. Kikuzaki H, Nakatani N. Antioxidant effects of some ginger constituents. J Food Sci. 1993;58(6):1407-10. doi: 10.1111/j.1365-2621.1993.tb06194.x.
  40. 40. Kleijnen J, Knipschild P. Gingko biloba for cerebral insufficiency. Br J Clin Pharmacol. 1992;34(4):352-58. doi: 10.1111/j.1365-2125.1992.tb05642.x, PMID 1457269.
  41. 41. Kuo YC, Kuo PL, Hsu YL, Cho CY, Lin CC. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Life Sci. 2006;78(22):2550-7. doi: 10.1016/j.lfs.2005.10.041, PMID 16337242.
  42. 42. Ladányi A, Tímár J, Lapis K. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol Immunother. 1993;36(2):123-26. doi: 10.1007/BF01754412, PMID 8425209.
  43. 43. Lampe JW, Martini MC, Kurzer MS, Adlercreutz H, Slavin JL. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr. 1994;60(1):122-28. doi: 10.1093/ajcn/60.1.122, PMID 8017326.
  44. 44. Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang ZY, Yang CS. Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett. 1993;68(2-3):231-6. doi: 10.1016/0304-3835(93)90151-x, PMID 8443796.
  45. 45. Ley CD, Horsman MR, Kristjansen PEG. Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure. Neoplasia. 2007;9(2):108-12. doi: 10.1593/neo.06733, PMID 17356706.
  46. 46. Liao LL, Kupchan SM, Horwitz SB. Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol Pharmacol. 1976;12(1):167-76. PMID 1256442.
  47. 47. Liu XM, Wung LG, Li HY, Ji XJ. Induction of differentiation and downregulation of c-myb gene expression in ML4 human myeloblastic leukemia cells by the clinically effective and leukemia agent meisoindigo. Biochem Pharmacol. 1996;51:1545-51.
  48. 48. Maliyakkal N, Udupa N, Pai KSR, Rangarajan A. Cytotoxic and apoptotic activities of extracts ofWithania somnifera and Tinospora cordifolia in human breast cancer cells. Int J Appl Res Nat Prod. 2013;6(4):1-10.
  49. 49. Mans DRA, Da Rocha AB, Schwartsmann G. Anti-cancer drug discovery and development inBrazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist. 2000;5(3):185-98. doi: 10.1634/theoncologist.5-3-185, PMID 10884497.
  50. 50. Milner JA. Garlic: its anticarcinogenic and anti-tumorigenic properties. Nutr Rev. 1996;54:82-6.
  51. 51. Mizuno T. Shiitake- Lentinus edodes: functional properties for medicinal and food purposes. Food Rev Int. 1995;11(1):109-28. doi: 10.1080/87559129509541022.
  52. 52. Mizuno T, Saito H, Nishitoba T, Kawagishi H. Antitumor active substances from mushrooms. Food Rev Int. 1995;11(1):23-61. doi: 10.1080/87559129509541018.
  53. 53. Mizuno T. Bioactive biomolecules of mushrooms: food function and medicinal effect ofmushroom fungi. Food Rev Int. 1995;11(1):5-21. doi: 10.1080/87559129509541017.
  54. 54. Molavi O, Ma Z, Mahmud A, Alshamsan A, Samuel J, Lai R et al. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm. 2008;347(1-2):118-27. doi: 10.1016/j.ijpharm.2007.06.032, PMID 17681440.
  55. 55. Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. PNAS. 2005;102:5998-6003.
  56. 56. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr. 1992;11(2):192-98. doi: 10.1080/07315724.1992.12098244, PMID 1578097.
  57. 57. Noble RL. The discovery of the vinca alkaloids- chemotherapeutic agents against cancer. Biochem Cell Biol. 1990;68(12):1344-51. doi: 10.1139/o90-197, PMID 2085431.
  58. 58. Okouneva T, Hill BT, Wilson L, Jordan MA. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther. 2003;2(5):427-36. PMID 12748304.
  59. 59. Pan L, Chai H, Kinghorn AD. The continuing search for antitumor agents from higher plants. Phytochem Lett. 2010;3(1):1-8. doi: 10.1016/j.phytol.2009.11.005, PMID 20228943.
  60. 60. Patil JB, Kim J, Jayaprakasha GK. Berberine induces apoptosis in breastcancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol. 2010;64(5):70-8.
  61. 61. Plengsuriyakarn T, Viyanant V, Eursitthichai V, Picha P, Kupradinun P, Itharat A et al. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models. BMC Complement Altern Med. 2012;12:23. doi: 10.1186/1472-6882-12-23, PMID 22448640.
  62. 62. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A et al. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 2000;60(11):2800-4. PMID 10850417.
  63. 63. Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation andpromotional stages of mammary tumorigenesis. Nutr Cancer. 1992;17(2):153-59. doi: 10.1080/01635589209514182, PMID 1584708.
  64. 64. Serraino M, Thompson LU. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett. 1991;60(2):135-42. doi: 10.1016/0304-3835(91)90220-c, PMID 1657368.
  65. 65. Simoens C, Lardon F, Pauwels B, De Pooter CMJ, Lambrechts HAJ, Pattyn GGO et al. Comparative study of theradiosensitising and cell cycle effects ofvinflunine and vinorelbine, in-vitro. BMC Cancer. 2008;8:65. doi: 10.1186/1471-2407-8-65, PMID 18312675.
  66. 66. Shoeb M, Celik S, Jaspars M, Kumarasamy Y, MacManus SM, Nahar L et al. Isolation, structure elucidation and bioactivity of schischkiniin, a unique indole alkaloid from the seeds ofCentaurea schischkinii. Tetrahedron. 2005;61(38):9001-06. doi: 10.1016/j.tet.2005.07.047.
  67. 67. Srivastava V, Negi AS, Kumar JK, Gupta MM, Khanuja SPS. Plant-based anticancer molecules: achemical and biological profile of some important leads. Bioorg Med Chem. 2005;13(21):5892-908. doi: 10.1016/j.bmc.2005.05.066, PMID 16129603.
  68. 68. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer. 1991;16(1):43-52. doi: 10.1080/01635589109514139, PMID 1656395.
  69. 69. Thomson P, Naylor MA, Everett SA, Stratford MRL, Lewis G, Hill S et al. Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4. Mol Cancer Ther. 2006;5(11):2886-94. doi: 10.1158/1535-7163.MCT-06-0429, PMID 17121936.
  70. 70. Tyler V. Herbs of choice- the therapeutic use of phytomedicinals. New york: Haworth Press; 1994. p. 32-3.
  71. 71. Wang F, Gao Y, Gao L, Xing T. Study on the electrochemical behavior of the anticancer herbal drug berberine and its analytical application. J Chin Chem Soc. 2011;58:61-8.
  72. 72. Wang J, Shimura K. Enhancing effect of antitumor polysaccharide from Astralagusor Radix Hedysarum on C3 cleavage production of macrophages in mice. Mem Inst Oswaldo Cruz. 1991;86(20):159-64.
  73. 73. Wasserman L, Avigad S, Nordenberg J, Berry E, Fenig E. The effect of aloe-emodin on the proliferation of a new merkel carcinoma cell line. Am J Derm Pathol. 2002;24(1):17-22.
  74. 74. Xie J, Ma T, Gu Y, Zhang X, Qiu X, Zhang L et al. Berbamine derivatives: a novel class ofcompounds for anti-leukemia activity. Eur J Med Chem. 2009;44(8):3293-8. doi: 10.1016/j.ejmech.2009.02.018, PMID 19285759.
  75. 75. Xu R, Dong Q, Yu Y, Zhao X, Gan X, Wu D et al. Berbamine: a novel inhibitor of bcr/ablfusion gene with potent anti-leukemiaactivity. Leuk Res. 2006;30(1):17-23. doi: 10.1016/j.leukres.2005.05.023, PMID 16023722.
  76. 76. Yue PYK, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DTP et al. Pharmacogenomics and the Yin/Yangactions of ginseng: antitumor, angiomodulating and steroidlikeactivities of ginsenosides. Chin Med. 2007;2(1):6. doi: 10.1186/1749-8546-2-6.
  77. 77. Yun TK, Choi SY. A case-control study of ginseng intake and cancer. Int J Epidemiol. 1990;19(4):871-76. doi: 10.1093/ije/19.4.871, PMID 2084014.
  78. 78. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a case control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev. 1995;4(4):401-08. PMID 7655337.
  79. 79. Yun TK. Experimental and epidemiological evidence of the cancer-preventive effects of panax ginseng C.A. Meyer. Nutr Rev. 1996;54(11 Pt 2):S71-81. doi: 10.1111/j.1753-4887.1996.tb03822.x, PMID 9110579.